Vertex Pharmaceuticals Inc / Ma

ADAGE CAPITAL PARTNERS GP, L.L.C. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

272,474

Value ($000)

123,529

Weight

0.2%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	123,529	0.2%	272,474	12/31/2025
2025 Q3	11/14/2025	188,964	0.3%	482,495	9/30/2025
2025 Q2	8/14/2025	79,331	0.1%	178,192	6/30/2025
2025 Q1	5/15/2025	237,400	0.4%	489,667	3/31/2025
2024 Q4	2/14/2025	84,261	0.1%	209,239	12/31/2024
2024 Q3	11/14/2024	161,083	0.3%	346,355	9/30/2024
2024 Q2	8/14/2024	157,097	0.3%	335,161	6/30/2024
2024 Q1	5/15/2024	146,411	0.3%	350,256	3/31/2024
2023 Q4	2/14/2024	122,144	0.3%	300,190	12/31/2023
2023 Q3	11/14/2023	104,323	0.2%	300,004	9/30/2023
2023 Q2	8/14/2023	107,696	0.2%	306,033	6/30/2023
2023 Q1	5/15/2023	106,617	0.2%	338,390	3/31/2023
2022 Q4	2/14/2023	51,949	0.1%	179,890	12/31/2022
2022 Q3	11/14/2022	97,622	0.2%	337,163	9/30/2022
2022 Q2	8/15/2022	161,192	0.4%	572,030	6/30/2022
2022 Q1	5/16/2022	207,025	0.4%	793,290	3/31/2022
2021 Q4	2/14/2022	48,507	0.1%	220,890	12/31/2021
2021 Q3	11/15/2021	31,555	0.1%	173,960	9/30/2021
2021 Q2	8/16/2021	68,340	0.1%	338,940	6/30/2021
2021 Q1	5/17/2021	190,766	0.4%	887,740	3/31/2021
2020 Q4	2/16/2021	161,217	0.4%	682,140	12/31/2020
2020 Q3	11/16/2020	79,184	0.2%	290,990	9/30/2020
2020 Q2	8/14/2020	116,023	0.3%	399,652	6/30/2020
2020 Q1	5/15/2020	216,761	0.6%	910,952	3/31/2020
2019 Q4	2/14/2020	177,284	0.4%	809,701	12/31/2019
2014 Q1	5/15/2014	117,217	0.3%	1,657,474	3/31/2014
2013 Q4	2/14/2014	282,865	0.7%	3,807,061	12/31/2013